Sunshine Biopharma Inc. (SBFM)
NASDAQ: SBFM
· Real-Time Price · USD
1.47
-0.02 (-1.34%)
At close: Aug 18, 2025, 3:59 PM
-1.34% (1D)
| Bid | 1.45 |
| Market Cap | 6.7M |
| Revenue (ttm) | 36.23M |
| Net Income (ttm) | -5.03M |
| EPS (ttm) | -15.02 |
| PE Ratio (ttm) | -0.1 |
| Forward PE | 17.31 |
| Analyst | Buy |
| Ask | 1.52 |
| Volume | 25,102 |
| Avg. Volume (20D) | 110,650 |
| Open | 1.47 |
| Previous Close | 1.49 |
| Day's Range | 1.45 - 1.50 |
| 52-Week Range | 1.17 - 3.90 |
| Beta | 0.24 |
About SBFM
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol SBFM
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for SBFM stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsEarnings Surprise
Sunshine Biopharma has released their quartely earnings
on Aug 12, 2025:
Next Earnings Release
Sunshine Biopharma Inc. is scheduled to release its earnings on
Nov 4, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
4 months ago
+3.2%
Sunshine Biopharma shares are trading higher after...
Unlock content with
Pro Subscription
4 months ago
+8.17%
Sunshine Biopharma shares are trading higher after the company reported a year-over-year increase in FY24 revenue results.
1 month ago · accessnewswire.com
Sunshine Biopharma Launches NIOPEG(R) Into $10 Billion Biologics MarketFORT LAUDERDALE, FL / ACCESS Newswire / July 2, 2025 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company offering and researching life-saving medicines in a variety of th...
